PLoS ONE (Jan 2012)

SUMO modification of Stra13 is required for repression of cyclin D1 expression and cellular growth arrest.

  • Yaju Wang,
  • Vinay Kumar Rao,
  • Wai Kay Kok,
  • Dijendra Nath Roy,
  • Sumita Sethi,
  • Belinda Mei Tze Ling,
  • Martin Beng Huat Lee,
  • Reshma Taneja

DOI
https://doi.org/10.1371/journal.pone.0043137
Journal volume & issue
Vol. 7, no. 8
p. e43137

Abstract

Read online

Stra13, a basic helix-loop-helix (bHLH) transcription factor is involved in myriad biological functions including cellular growth arrest, differentiation and senescence. However, the mechanisms by which its transcriptional activity and function are regulated remain unclear. In this study, we provide evidence that post-translational modification of Stra13 by Small Ubiquitin-like Modifier (SUMO) dramatically potentiates its ability to transcriptionally repress cyclin D1 and mediate G(1) cell cycle arrest in fibroblast cells. Mutation of SUMO acceptor lysines 159 and 279 located in the C-terminal repression domain has no impact on nuclear localization; however, it abrogates association with the co-repressor histone deacetylase 1 (HDAC1), attenuates repression of cyclin D1, and prevents Stra13-mediated growth suppression. HDAC1, which promotes cellular proliferation and cell cycle progression, antagonizes Stra13 sumoylation-dependent growth arrest. Our results uncover an unidentified regulatory axis between Stra13 and HDAC1 in progression through the G(1)/S phase of the cell cycle, and provide new mechanistic insights into regulation of Stra13-mediated transcriptional repression by sumoylation.